CRIS
Price
$14.55
Change
-$0.67 (-4.40%)
Updated
Apr 19, 1:26 PM EST
FBRX
Price
$0.76
Change
-$0.02 (-2.56%)
Updated
Apr 19, 1:15 PM EST
24 days until earnings call
Ad is loading...

Analysis and predictions CRIS vs FBRX

Header iconCRIS vs FBRX Comparison
Open Charts CRIS vs FBRXBanner chart's image
Curis
Price$14.55
Change-$0.67 (-4.40%)
Volume$100
CapitalizationN/A
Forte Biosciences
Price$0.76
Change-$0.02 (-2.56%)
Volume$110
CapitalizationN/A
View a ticker or compare two or three
CRIS vs FBRX Comparison Chart

Loading...

CRISDaily Signal changed days agoGain/Loss if shorted
 
Show more...
FBRXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
CRIS vs. FBRX commentary
Apr 20, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRIS is a Hold and FBRX is a Hold.

COMPARISON
Comparison
Apr 20, 2024
Stock price -- (CRIS: $15.22 vs. FBRX: $0.78)
Brand notoriety: CRIS and FBRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRIS: 65% vs. FBRX: 175%
Market capitalization -- CRIS: $88.06M vs. FBRX: $28.39M
CRIS [@Biotechnology] is valued at $88.06M. FBRX’s [@Biotechnology] market capitalization is $28.39M. The market cap for tickers in the [@Biotechnology] industry ranges from $553.33B to $0. The average market capitalization across the [@Biotechnology] industry is $2.51B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRIS’s FA Score shows that 0 FA rating(s) are green whileFBRX’s FA Score has 0 green FA rating(s).

  • CRIS’s FA Score: 0 green, 5 red.
  • FBRX’s FA Score: 0 green, 5 red.
According to our system of comparison, FBRX is a better buy in the long-term than CRIS.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRIS’s TA Score shows that 5 TA indicator(s) are bullish while FBRX’s TA Score has 6 bullish TA indicator(s).

  • CRIS’s TA Score: 5 bullish, 5 bearish.
  • FBRX’s TA Score: 6 bullish, 3 bearish.
According to our system of comparison, FBRX is a better buy in the short-term than CRIS.

Price Growth

CRIS (@Biotechnology) experienced а -4.28% price change this week, while FBRX (@Biotechnology) price change was +8.33% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.81%. For the same industry, the average monthly price growth was -5.21%, and the average quarterly price growth was +1226.26%.

Reported Earning Dates

CRIS is expected to report earnings on Nov 02, 2023.

FBRX is expected to report earnings on Aug 12, 2024.

Industries' Descriptions

@Biotechnology (-6.81% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for CRIS with price predictions.
OPEN
A.I.dvisor published
a Summary for FBRX with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
CRIS($88.1M) has a higher market cap than FBRX($28.4M). CRIS YTD gains are higher at: 19.373 vs. FBRX (-5.075).
CRISFBRXCRIS / FBRX
Capitalization88.1M28.4M310%
EBITDAN/AN/A-
Gain YTD19.373-5.075-382%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
CRIS vs FBRX: Fundamental Ratings
CRIS
FBRX
OUTLOOK RATING
1..100
8720
VALUATION
overvalued / fair valued / undervalued
1..100
70
Overvalued
98
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9998
PRICE GROWTH RATING
1..100
3544
P/E GROWTH RATING
1..100
10052
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CRIS's Valuation (70) in the Biotechnology industry is in the same range as FBRX (98) in the null industry. This means that CRIS’s stock grew similarly to FBRX’s over the last 12 months.

CRIS's Profit vs Risk Rating (100) in the Biotechnology industry is in the same range as FBRX (100) in the null industry. This means that CRIS’s stock grew similarly to FBRX’s over the last 12 months.

FBRX's SMR Rating (98) in the null industry is in the same range as CRIS (99) in the Biotechnology industry. This means that FBRX’s stock grew similarly to CRIS’s over the last 12 months.

CRIS's Price Growth Rating (35) in the Biotechnology industry is in the same range as FBRX (44) in the null industry. This means that CRIS’s stock grew similarly to FBRX’s over the last 12 months.

FBRX's P/E Growth Rating (52) in the null industry is somewhat better than the same rating for CRIS (100) in the Biotechnology industry. This means that FBRX’s stock grew somewhat faster than CRIS’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CRISFBRX
RSI
ODDS (%)
Bearish Trend 2 days ago
88%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
75%
MACD
ODDS (%)
N/A
Bullish Trend 2 days ago
77%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
73%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
71%
Advances
ODDS (%)
Bullish Trend 3 days ago
80%
Bullish Trend 2 days ago
75%
Declines
ODDS (%)
Bearish Trend 5 days ago
86%
Bearish Trend 24 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
88%
Bearish Trend 2 days ago
89%
Aroon
ODDS (%)
Bullish Trend 2 days ago
88%
Bullish Trend 2 days ago
83%
View a ticker or compare two or three
Ad is loading...
CRISDaily Signal changed days agoGain/Loss if shorted
 
Show more...
FBRXDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MAIFF0.22N/A
+1.29%
Minera Alamos
NSANY7.390.04
+0.54%
Nissan Motor Co Ltd
ISNPY21.330.08
+0.37%
Intesa Sanpaolo SPA
KOTMY14.72-0.22
-1.47%
Koito Manufacturing
BTCWF0.02N/A
-9.00%
Bluesky Digital Assets Corp

CRIS and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRIS has been loosely correlated with ORMP. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if CRIS jumps, then ORMP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRIS
1D Price
Change %
CRIS100%
-4.58%
ORMP - CRIS
34%
Loosely correlated
-5.58%
GOSS - CRIS
31%
Poorly correlated
-1.71%
ALNY - CRIS
31%
Poorly correlated
-0.11%
AMRN - CRIS
30%
Poorly correlated
-4.94%
AXON - CRIS
30%
Poorly correlated
-0.74%
More

FBRX and

Correlation & Price change

A.I.dvisor tells us that FBRX and NVIVQ have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that FBRX and NVIVQ's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FBRX
1D Price
Change %
FBRX100%
+5.41%
NVIVQ - FBRX
32%
Poorly correlated
-1.13%
EQ - FBRX
32%
Poorly correlated
-3.35%
FBIO - FBRX
32%
Poorly correlated
+2.26%
AXON - FBRX
31%
Poorly correlated
-0.74%
CRIS - FBRX
30%
Poorly correlated
-4.58%
More